Mercury contamination of rat amylin mimics vasoactivity and cytotoxic effects

Heiko A Golpon1, Annette Püchner, Lothar Schmidt

  • 1Department of Internal Medicine, Philipps University of Marburg, Baldinger Strasse, 35033, Marburg, Germany. Heiko.Golpon@medizin.uni-magdeburg.de

Peptides
|November 13, 2003
PubMed

Insights

Mercury contamination in rat amylin can mimic toxic effects typically seen with human amylin (hIAPP). This contamination, possibly from peptide synthesis, caused unexpected vasoactive and cytotoxic impacts on blood vessels.

Area of Science:

  • Biochemistry
  • Toxicology
  • Physiology

Background:

  • Human amylin (hIAPP) is known to form fibrils and exhibit toxic effects, unlike rat amylin.
  • Rat amylin typically does not display fibril-forming capacity or associated toxicity.
  • Contamination in peptide preparations can alter experimental results.

Purpose of the Study:

  • To investigate the cause of unexpected vasoactive and cytotoxic effects observed with commercial rat amylin.
  • To determine if mercury contamination could be responsible for these effects.
  • To understand the implications of contamination in peptide-based research.

Main Methods:

  • Analysis of commercial rat amylin for contaminants.
  • In vitro testing of rat amylin preparations on isolated blood vessels.
  • Assessment of vasoactive and cytotoxic responses.

Main Results:

  • Commercial rat amylin exhibited vasoactive and cytotoxic effects on isolated blood vessels.
  • Mercury was identified as a contaminant in the rat amylin preparation.
  • The observed effects mimicked those typically associated with human amylin.

Conclusions:

  • Mercury contamination in rat amylin can induce toxicity and vasoactivity, mimicking human amylin (hIAPP) effects.
  • Peptide synthesis, particularly the use of mercuric acetate to cleave acetamidomethyl (Acm) protecting groups, is a likely source of contamination.
  • Researchers must be vigilant about potential contaminants in synthetic peptides to ensure experimental validity.

Related Concept Videos